Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study

BACKGROUND: Patients with hypertension and cardiovascular disease (CVD), diabetes, or chronic kidney disease (CKD) usually require two or more antihypertensive agents to achieve blood pressure (BP) goals. METHODS: The efficacy/safety of olmesartan (OM) 40 mg, amlodipine besylate (AML) 10 mg, and hyd...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kereiakes, Dean J, Chrysant, Steven G, Izzo, Joseph L, Littlejohn, Thomas, Melino, Michael, Lee, James, Fernandez, Victor, Heyrman, Reinilde
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Original Investigation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3547771/
https://ncbi.nlm.nih.gov/pubmed/23110471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-11-134
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki